Health Care/Hospital

TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma

NANJING, China, Nov. 7, 2019 /PRNewswire/ -- TransThera Biosciences Co. Ltd, announced today that company received Orphan Drug Designation from US Food and Drug Administration (FDA) for TT-00420, a clinical stage investigational drug, for the treatment of cholangiocarcinoma. Dr. Frank Wu, Founde...

2019-11-07 20:08 302

TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million

HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subsidiaries, the "Group", stock code: 1875) was well received by the capi...

2019-11-07 19:04 5383

Bactiguard Holding AB (publ): Interim Report for Q3 2019

STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactigua...

2019-11-07 15:23 5260

MEBO Group exhibits new products on CIIE again to promote the internationalization of traditional Chinese medicines (TCMS)

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- The 2nd China International Import Expo ( CIIE) is held in Shanghai, China, from November 5 to November 10, 2019. MEBO International, the US company of MEBO Group, attended the Expo again as a typical representative of regenerative medical technology. The ne...

2019-11-07 14:43 406

FlexEnable Acquires Merck's OTFT Materials Portfolio for Flexible Displays

CAMBRIDGE, England, Nov. 7, 2019 /PRNewswire/ -- FlexEnable, the leader in the development and industrialisation of flexible organic electronics, has acquired Merck's portfolio of best-in-class, high-performance Organic Thin-Film Transistor (OTFT) materials, including revolutionary and highly-pat...

2019-11-07 12:00 533

ASH 2019 | CStone's anti-PD-L1 antibody demonstrates a complete response rate of 31.8% in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma

SUZHOU, China, Nov. 7, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that an abstract on the CS1001-201 trial (Abstract #2833) was accepted by the 2019 American Society of Hematology (ASH) Annual Meeting and has been published online yesterday...

2019-11-07 11:02 438

Medical Director of Amaris B. Clinic Shares Little-known Permanent Side Effects of Cryolipolysis (Fat Freezing Treatments)

SINGAPORE, Nov. 6, 2019 /PRNewswire/ -- Cryolipolysis, also known as Fat Freezing, is thriving as a non-invasive fat reduction treatment option in Singapore as with the rest of the world. It works by gently and efficiently targeting fat cells underneath the skin via targeted and controlled cooling...

2019-11-07 09:42 404

Johnson & Johnson and Lazada Group Enter Strategic Partnership

SHANGHAI, Nov. 7, 2019 /PRNewswire/ -- Johnson & Johnson Consumer Health ("Johnson & Johnson") and Lazada Group ("Lazada") today entered a strategic partnership to incubate more brands for success in Southeast Asian and Chinese markets. Qian...

2019-11-07 09:00 651

First Asia-Pacific hospital treats patients with RayStation and Radixact

SUNNYVALE, California, Nov. 7, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) –Thailand's Lopburi Cancer Hospital, a center of excellence for cancer treatment, is the first in theAsia-Pacific region to clinically use the combination of RaySearch's treatment planning system RayStation® w...

2019-11-07 09:00 490

AiCure Raises $24.5 Million Series C Round to Broaden Its Strategic Value for Life Sciences

NEW YORK, Nov. 7, 2019 /PRNewswire/ -- AiCure, recognized as one of the world's 100 most innovative artificial intelligence companies, announced a Series C fundraising round totaling$24.5 million. The financing was led by Palisades Growth Capital (PGC) with new investors from Singtel Innov8 (Inno...

2019-11-07 08:01 543

Bioeq Announces Coherus as Marketing and Distribution Partner for Its Biosimilar to Lucentis® (ranibizumab) in the U.S.

- Bioeq agreement brings promise of their leading Lucentis® biosimilar for the treatment of retinopathies one step nearer for U.S. patients - ZÜRICH, Nov. 7, 2019 /PRNewswire/ -- Bioeq IP AG ("Bioeq") today announced that it signed a license and development agreement with Coherus BioSciences, In...

2019-11-07 05:14 520

Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364

SHANGHAI and LONDON, Nov. 7, 2019 /PRNewswire/ -- Antengene Corporation today announced that it has entered into a licensing agreement with AstraZeneca (LSE/STO/NYSE: AZN) under which Antengene has been granted the exclusive global rights to further develop and commercialize AZD0364. Antengene Co...

2019-11-07 01:40 647

Henlius HLX01 (Rituximab Injection) Wins "Biosimilar Initiative of the Year" at Global Generics & Biosimilars Awards 2019

SHANGHAI, Nov. 7, 2019 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), a leading biopharmaceutical company inChina focusing on oncology and autoimmune diseases, won the award of "Biosimilar Initiative of the Year" (HLX01, rituximab injection) and was also shortlisted for the award of "t...

2019-11-07 01:00 504

Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting

-- MAVIS Study Identifies Most Responsive Patient Subpopulations, Supporting the Continued Study of Adjuvant Treatment in Localized Melanoma Patients -- SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Polynoma LLC, a U.S. immuno-oncology focused biopharmaceutical company and wholly-owned subsidiary ofHon...

2019-11-06 20:00 4951

SHL Celebrates Grand Opening of its Liufu Site in Taoyuan, Taiwan

    TAOYUAN, Taiwan, Nov. 6, 2019 /PRNewswire/ -- On November 5, SHL Group, a global leader in the design, development, and manufacturing of drug delivery devices, held the inauguration of its new Liufu site in Taoyuan City,Taiwan. SHL’s ...

2019-11-06 19:00 506

EpiVax Announces Publication of Antigen-Specific Tolerance Induction by Tregitope in Nature Scientific Reports

PROVIDENCE, Rhode Island, Nov. 6, 2019 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" inS...

2019-11-06 18:01 393

Nanoform Wins the CPhI Excellence in Pharma Award for Formulation

HELSINKI, Nov. 6, 2019 /PRNewswire/ -- Nanoform, an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform's commitment to innovation...

2019-11-06 17:21 372

ZEISS Again at CIIE, Leveraging Innovation with China Partners for Mutual Benefit and Win-Win Results

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- The second China International Import Expo (CIIE) kicked off yesterday at the National Exhibition and Convention Center in Shanghai, building a platform for the integration of global technology products and solutions into the Chinese market.Participating aga...

2019-11-06 16:34 354

WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies

SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- WuXi AppTec announced today that it has received investment grade corporate credit ratings from three global rating agencies: Moody's (Baa3), S&P Global Ratings (BBB-), and Fitch Ratings (BBB-); all three agencies maintain a stable outlook on WuXi AppTec. Th...

2019-11-06 16:00 250

Ping An Joins UNLEASH 2019 to Support Innovation for Sustainable Development Goals

HONG KONG and SHANGHAI, Nov. 6, 2019 /PRNewswire/ -- Ping An Insurance (Group) of Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEx: 2318; SSE: 601318) is proud to represent the financial technology sector as a partner of UNLEASH 2019, the global innovation lab for sustainable devel...

2019-11-06 14:54 5611
12345678 ... 759